Latin America Flow Cytometry Market Analysis By Technology (Cell Based, Bead Based), By Product and Services (Instruments, Reagents & Consumables, Accessories, Software), By Application (Research, Clinical, Pharmaceutical, Apoptosis, Cell Sorting, Cell Cycle Analysis, Immunology, Cell Viability, Industrial, Cancer, Hematology, Immunodeficiency Diseases), By End-use (Commercial Organization, Hospitals, Academic Institutes, Clinical Testing Labs) And Segment Forecasts To 2022

Published: Nov, 2015 | Pages: 91 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

Latin America flow cytometry market is expected to reach USD 566.5 million by 2022, according to a new report by Grand View Research Inc. Increasing target disease population base, high unmet needs and demand for rapid, accurate diagnostic tools are key factors driving the Latin America flow cytometry market over the forecast period.

Increasing demand for faster and accurate leukemia prognostic tools coupled with increasing prevalence rate is expected to provide this market with lucrative growth platform in near future. In addition, research pertaining to drug development, stem cell therapy and in vitro toxicity testing are expected to fuel the market growth over the forecast period.

According to the data published by WHO, it has been estimated that in 2012, cancer incidences (cases per year) were nearly 603,400 patients. Furthermore, risk of getting cancer before age 75 accounted for 18% in Latin America. Moreover, experts suggest that on account of rising prevalence of infectious diseases, the aforementioned prevalence rate is expected to rise over the next decade. All the aforementioned facts are expected to push demand for rapid diagnostic tools which in turn is expected to provide lucrative growth to this industry in near future.

Further key findings from the study suggest:

Bead based technology is expected to grow at a lucrative CAGR of about 12.0% over the forecast period. The bead based flow cytometry is used to measure a variety of intracellular proteins and solubles including growth factors, phosphorylated cell signaling proteins, chemokines and cytokines. Rising demand for infectious disease diagnostic assays is expected to spearhead growth during the forecast period.
Flow cytometry found the largest application in research in 2014. The segment is likely to dominate the market throughout the forecast period accounting for over 54.0% of the revenue by 2022. This dominance is attributed to rising research activities pertinent to leukemia and increasing usage of ISH probes such as miRCURY LNA microRNA and Prime Flow RNA for RNA research and quantification.
The clinical application segment of this market is majorly driven by the growing demand of immunodeficiency related R&D. The segment accounted for over 29.0% of the market in 2014, owing to the rising prevalence of immunodeficiency diseases in children and infants.
The market for instruments held an appreciable revenue share of over 43.0% in 2014. The introduction of novel technology such as multicolor flow cytometer and simultaneous multiparameter detection features are some factors contributing towards robust market growth. In addition, growing R&D activities, and widening application of flow cytometry applications in drug discovery & development, genomic and molecular analysis are also expected to drive segment growth during the forecast period.
The clinical testing labs segment is expected to grow at the fastest CAGR of 10.7% over the forecast period. Rising adoption of flow cytometry owing to the associated benefits such as fast results, and providing quantitative information for clinical trials of drug compound in phase I clinical trials are expected to fuel demand during the forecast period.
Key players of this market include Life Technologies Corporation, Beckman Coulter Inc, EMD Millipore Corp, Stratedigm, Sysmex Corporation, Miltenyi Biotec, Becton Dickinson and Co and Luminex Corporation is major players in the Latin America flow cytometry market.
Market participants are striving to gain competitive advantage by introducing new products and services mostly via collaborative agreements. For example, in September 2015, BD Life Sciences entered into a collaborative agreement with Seegene for developing multiplex PCR reagents used in BD max system.

 Table of Content

Chapter 1 Methodology and Scope
              1.1 Research Methodology
              1.2 Research Scope & Assumptions
              1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Flow Cytometry Market Industry Outlook
              3.1 Market segmentation
              3.2 Market size and growth prospects
              3.3 Flow cytometry: Market dynamics
                 3.3.1 Market Driver Analysis
                       3.3.1.1 Growing prevalence of target disorders
                       3.3.1.2 Increasing demand for in vitro diagnostics
                       3.3.1.3 Growing R&D investments in biotechnology sector
                       3.3.1.4 Technological advancements
                       3.3.1.5 Increasing demand for point of care diagnostics
                 3.3.2 Market Restraint Analysis
                       3.3.2.1 High cost of instruments
              3.4 Key Opportunities Prioritized
              3.5 Industry analysis - Porter's
              3.6 Flow cytometry competative landscape, 2014
                 3.6.1 Market position analysis
              3.7 Flow cytometry market PESTEL Analysis
Chapter 4 Flow Cytometry Market Technology Outlook
              4.1 Flow cytometry market share by technology, 2014 & 2022
              4.2 Cell based flow cytometry
                 4.2.1 Cell based flow cytometry market, 2012 - 2022 (USD Million)
              4.3 Bead based flow cytometry
                 4.3.1 Bead based flow cytometry market, 2012 - 2022 (USD Million)
Chapter 5 Flow Cytometry Market Product Outlook
              5.1 Flow cytometry market share by product, 2014 & 2022
              5.2 Flow cytometer instruments
                 5.2.1 Flow cytometer instruments market, 2012 - 2022 (USD Million)
              5.3 Reagents & consumables
                 5.3.1 Reagents & consumables market, 2012 - 2022 (USD Million)
              5.4 Software
                 5.4.1 Software market, 2012 - 2022 (USD Million)
              5.5 Accessories
                 5.5.1 Accessories market, 2012 - 2022 (USD Million)
              5.6 Services
                 5.6.1 Services market, 2012 - 2022 (USD Million)
Chapter 6 Flow Cytometry Application Outlook
              6.1 Flow cytometry revenue share by application, 2014 & 2022
              6.2 Research
                 6.2.1 Research market, 2012 - 2022 (USD Million)
                 6.2.2 Pharmaceutical
                       6.2.2.1 Pharmaceutical market, 2012 - 2022 (USD Million)
                       6.2.2.2 Drug discovery
                               6.2.2.2.1 Drug discovery market, 2012 - 2022 (USD Million)
                       6.2.2.3 Stem cell research
                               6.2.2.3.1 Stem cell research market, 2012 - 2022 (USD Million)
                       6.2.2.4 In vitro toxicity testing
                               6.2.2.4.1 In vitro toxicity testing market, 2012 - 2022 (USD Million)
                 6.2.3 Apoptosis
                       6.2.3.1 Apoptosis market, 2012 - 2022 (USD Million)
                 6.2.4 Cell sorting
                       6.2.4.1 Cell sorting market, 2012 - 2022 (USD Million)
                 6.2.5 Cell cycle analysis
                       6.2.5.1 Cell cycle analysis market, 2012 - 2022 (USD Million)
                 6.2.6 Immunology
                       6.2.6.1 Immunology market, 2012 - 2022 (USD Million)
                 6.2.7 Cell viability
                       6.2.7.1 Cell viability market, 2012 - 2022 (USD Million)
              6.3 Industrial
                 6.3.1 Industrial market, 2012 - 2022 (USD Million)
              6.4 Clinical
                 6.4.1 Clinical market, 2012 - 2022 (USD Million)
                 6.4.2 Cancer
                       6.4.2.1 Cancer market, 2012 - 2022 (USD Million)
                 6.4.3 Organ transplantation
                       6.4.3.1 Organ transplantation market, 2012 - 2022 (USD Million)
                 6.4.4 Immunodeficiency diseases
                       6.4.4.1 Immunodeficiency diseases market, 2012 - 2022 (USD Million)
                 6.4.5 Hematology
                       6.4.5.1 Hematology analysis market, 2012 - 2022 (USD Million)
Chapter 7 Flow Cytometry Market End-Use Outlook
              7.1 Flow cytometry market share by end-use, 2014 & 2022
              7.2 Commercial organization
                 7.2.1 Commercial organization market, 2012 - 2022 (USD Million)
              7.3 Hospitals
                 7.3.1 Hospitals market, 2012 - 2022 (USD Million)
              7.4 Academic institutes
                 7.4.1 Academic institutes market, 2012 - 2022 (USD Million)
              7.5 Clinical testing labs
                 7.5.1 Clinical testing labs market, 2012 - 2022 (USD Million)
Chapter 8 Flow Cytometry Country Outlook
              8.1 Flow cytometry market share, by country, 2014 & 2022
              8.2 Mexico
                 8.2.1 Mexico flow cytometry market, 2012 - 2022 (USD Million)
              8.3 Guatemala
                 8.3.1 Guatemala flow cytometry market, 2012 - 2022 (USD Million)
              8.4 Costa Rica
                 8.4.1 Costa Rica flow cytometry market, 2012 - 2022 (USD Million)
              8.5 Panama
                 8.5.1 Panama Flow cytometry market, 2012 - 2022 (USD Million)
              8.6 Republica Dominicana
                 8.6.1 Republica Dominicana flow cytometry market, 2012 - 2022 (USD Million)
              8.7 Cuba
                 8.7.1 Cuba flow cytometry market, 2012 - 2022 (USD Million)
              8.8 Brazil
                 8.8.1 Brazil Flow cytometry market, 2012 - 2022 (USD Million)
              8.9 Colombia
                 8.9.1 Colombia flow cytometry market, 2012 - 2022 (USD Million)
              8.10 Venezuela
                 8.10.1 Venezuela flow cytometry market, 2012 - 2022 (USD Million)
              8.11 Ecuador
                 8.11.1 Ecuador Flow cytometry market, 2012 - 2022 (USD Million)
              8.12 Peru
                 8.12.1 Peru flow cytometry market, 2014 - 2022 (USD Million)
              8.13 Argentina
                 8.13.1 Argentina flow cytometry market, 2012 - 2022 (USD Million)
              8.14 Chile
                 8.14.1 Chile Flow cytometry market, 2012 - 2022 (USD Million)
              8.15 Uruguay
                 8.15.1 Uruguay flow cytometry market, 2012 - 2022 (USD Million)
Chapter 9 Competitive Landscape
              9.1 Beckman Coulter Inc.
                 9.1.1 Company Overview
                 9.1.2 Financial Performance
                 9.1.3 Product Benchmarking
                 9.1.4 Strategic Initiatives
              9.2 Becton Dickinson and Co.
                 9.2.1 Company Overview
                 9.2.2 Financial Performance
                 9.2.3 Product Benchmarking
                 9.2.4 Strategic Initiatives
              9.3 Sysmex Corporation
                 9.3.1 Company Overview
                 9.3.2 Financial Performance
                 9.3.3 Product Benchmarking
                 9.3.4 Strategic Initiatives
              9.4 Agilent Technologies
                 9.4.1 Company Overview
                 9.4.2 Financial Performance
                 9.4.3 Product Benchmarking
                 9.4.4 Strategic Initiatives
              9.5 EMD Millipore Corp.
                 9.5.1 Company Overview
                 9.5.2 Financial Performance
                 9.5.3 Product/service Benchmarking
                 9.5.4 Strategic Initiatives
              9.6 Apogee Flow Systems
                 9.6.1 Company Overview
                 9.6.2 Financial Performance
                 9.6.3 Product Benchmarking
              9.7 Bio-Rad
                 9.7.1 Company Overview
                 9.7.2 Financial Performance
                 9.7.3 Product Benchmarking
                 9.7.4 Strategic Initiatives
              9.8 Life Technologies Corporation
                 9.8.1 Company Overview
                 9.8.2 Financial Performance
                 9.8.3 Product Benchmarking
                 9.8.4 Strategic Initiatives
              9.9 Stratedigm
                 9.9.1 Company Overview
                 9.9.2 Financial Performance
                 9.9.3 Product Benchmarking
              9.10 Luminex Corporation
                 9.10.1 Company Overview
                 9.10.2 Financial Performance
                 9.10.3 Product Benchmarking
                 9.10.4 Strategic Initiatives
              9.11 Partec
                 9.11.1 Company Overview
                 9.11.2 Financial Performance
                 9.11.3 Product Benchmarking
                 9.11.4 Strategic Initiatives
              9.12 Miltenyi Biotec
                 9.12.1 Company Overview
                 9.12.2 Financial Performance
                 9.12.3 Product Benchmarking
                 9.12.4 Strategic Initiatives
              9.13 GE Healthcare
                 9.13.1 Company Overview
                 9.13.2 Financial Performance
                 9.13.3 Product Benchmarking
                 9.13.4 Strategic Initiatives
              9.14 eBioscience Inc.
                 9.14.1 Company Overview
                 9.14.2 Financial Performance
                 9.14.3 Product Benchmarking
                 9.14.4 Strategic Initiatives

List of Tables

TABLE 1 Flow cytometry- Industry Snapshot & Key Buying Criteria, 2012 - 2022
TABLE 2 Latin American flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 3 Latin America Flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 4 Latin America flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 5 Latin America research market, by type, 2012 - 2022 (USD Million)
TABLE 6 Latin America clinical market, by type, 2012 - 2022 (USD Million)
TABLE 7 Latin America flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 8 Latin America Flow cytometry market, by country, 2012 - 2022 (USD Million)
TABLE 9 Flow cytometry- Key market driver analysis
TABLE 10 Flow cytometry market - Key market restraint analysis
TABLE 11 Mexico flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 12 Mexico Flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 13 Mexico flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 14 Mexico research market, by type, 2012 - 2022 (USD Million)
TABLE 15 Mexico pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 16 Mexico clinical market, by type, 2012 - 2022 (USD Million)
TABLE 17 Mexico flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 18 Guatemala flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 19 Guatemala Flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 20 Guatemala flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 21 Guatemala research market, by type, 2012 - 2022 (USD Million)
TABLE 22 Guatemala pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 23 Guatemala clinical market, by type, 2012 - 2022 (USD Million)
TABLE 24 Guatemala flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 25 Costa Rica flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 26 Costa Rica Flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 27 Costa Rica flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 28 Costa Rica research market, by type, 2012 - 2022 (USD Million)
TABLE 29 Costa Rica pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 30 Costa Rica clinical market, by type, 2012 - 2022 (USD Million)
TABLE 31 Costa Rica flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 32 Panama flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 33 Panama Flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 34 Panama flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 35 Panama research market, by type, 2012 - 2022 (USD Million)
TABLE 36 Panama pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 37 Panama clinical market, by type, 2012 - 2022 (USD Million)
TABLE 38 Panama flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 39 Republica Dominicana flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 40 Republica Dominicana flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 41 Republica Dominicana flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 42 Republica Dominicana research market, by type, 2012 - 2022 (USD Million)
TABLE 43 Republica Dominicana pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 44 Republica Dominicana clinical market, by type, 2012 - 2022 (USD Million)
TABLE 45 Republica Dominicana flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 46 Cuba flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 47 Cuba flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 48 Cuba flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 49 Cuba research market, by type, 2012 - 2022 (USD Million)
TABLE 50 Cuba pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 51 Cuba clinical market, by type, 2012 - 2022 (USD Million)
TABLE 52 Cuba flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 53 Brazil flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 54 Brazil Flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 55 Brazil flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 56 Brazil research market, by type, 2012 - 2022 (USD Million)
TABLE 57 Brazil pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 58 Brazil clinical market, by type, 2012 - 2022 (USD Million)
TABLE 59 Brazil flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 60 Colombia flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 61 Colombia flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 62 Colombia flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 63 Colombia research market, by type, 2012 - 2022 (USD Million)
TABLE 64 Colombia pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 65 Colombia clinical market, by type, 2012 - 2022 (USD Million)
TABLE 66 Colombia flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 67 Venezuela flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 68 Venezuela flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 69 Venezuela flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 70 Venezuela research market, by type, 2012 - 2022 (USD Million)
TABLE 71 Venezuela pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 72 Venezuela clinical market, by type, 2012 - 2022 (USD Million)
TABLE 73 Venezuela flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 74 Ecuador flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 75 Ecuador flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 76 Ecuador flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 77 Ecuador research market, by type, 2012 - 2022 (USD Million)
TABLE 78 Ecuador pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 79 Ecuador clinical market, by type, 2012 - 2022 (USD Million)
TABLE 80 Ecuador flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 81 Peru flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 82 Peru flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 83 Peru flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 84 Peru research market, by type, 2012 - 2022 (USD Million)
TABLE 85 Peru pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 86 Peru clinical market, by type, 2012 - 2022 (USD Million)
TABLE 87 Peru flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 88 Argentina flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 89 Argentina flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 90 Argentina flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 91 Argentina research market, by type, 2012 - 2022 (USD Million)
TABLE 92 Argentina pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 93 Argentina clinical market, by type, 2012 - 2022 (USD Million)
TABLE 94 Argentina flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 95 Chile flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 96 Chile flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 97 Chile flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 98 Chile research market, by type, 2012 - 2022 (USD Million)
TABLE 99 Chile pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 100 Chile clinical market, by type, 2012 - 2022 (USD Million)
TABLE 101 Chile flow cytometry market, by end-use, 2012 - 2022 (USD Million)
TABLE 102 Uruguay flow cytometry market, by technology, 2012 - 2022 (USD Million)
TABLE 103 Uruguay flow cytometry market, by product & services, 2012 - 2022 (USD Million)
TABLE 104 Uruguay flow cytometry market, by application, 2012 - 2022 (USD Million)
TABLE 105 Uruguay research market, by type, 2012 - 2022 (USD Million)
TABLE 106 Uruguay pharmaceutical market, by type, 2012 - 2022 (USD Million)
TABLE 107 Uruguay clinical market, by type, 2012 - 2022 (USD Million)
TABLE 108 Uruguay flow cytometry market, by end-use, 2012 - 2022 (USD Million)